FANCA pathogenic variants

Biomarker type: Germline variant

Gene context: FANCA

Chromosome: 16

Requires pathogenic: True

Precision oncology relationships for therapeutic response involving this biomarker.

Organizations	Biomarkers	Cancer types	Therapies
FDA (1) HC (1)	FANCA pathogenic variants	Prostate Adenocarcinoma	Enzalutamide, Talazoparib